147 related articles for article (PubMed ID: 21643956)
1. CXCL12 G801A polymorphism and breast cancer risk: a meta-analysis.
Shen W; Cao X; Xi L; Deng L
Mol Biol Rep; 2012 Feb; 39(2):2039-44. PubMed ID: 21643956
[TBL] [Abstract][Full Text] [Related]
2. The CXCL12 G801A polymorphism and cancer risk: evidence from 17 case-control studies.
Gong H; Tan M; Wang Y; Shen B; Liu Z; Zhang F; Liu Y; Qiu J; Bao E; Fan Y
Gene; 2012 Nov; 509(2):228-31. PubMed ID: 22939870
[TBL] [Abstract][Full Text] [Related]
3. The G801A polymorphism in the CXCL12 gene and risk of breast carcinoma: evidence from a meta-analysis including 2,931 subjects.
Xia Y; Guo XG; Ji TX
Asian Pac J Cancer Prev; 2014; 15(6):2857-61. PubMed ID: 24761914
[TBL] [Abstract][Full Text] [Related]
4. The CXCL12 G801A polymorphism is associated with cancer risk: a meta-analysis.
Zhu K; Jiang B; Hu R; Yang Y; Miao M; Li Y; Liu Z
PLoS One; 2014; 9(9):e108953. PubMed ID: 25268356
[TBL] [Abstract][Full Text] [Related]
5. CXCL12 G801A polymorphism contributes to cancer susceptibility: a meta-analysis.
Ma XY; Jin Y; Sun HM; Yu L; Bai J; Chen F; Fu SB
Cell Mol Biol (Noisy-le-grand); 2012 Jun; 58 Suppl():OL1702-8. PubMed ID: 22762525
[TBL] [Abstract][Full Text] [Related]
6. CXCL12 G801A polymorphism and cancer risk: An updated meta-analysis.
Meng D; Wu YX; Heerah V; Peng S; Chu MD; Xu YJ; Xiong WN; Xu SY
J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):319-326. PubMed ID: 26072067
[TBL] [Abstract][Full Text] [Related]
7. CXCL12-3' G801A polymorphism is not a risk factor for breast cancer.
Kruszyna Ł; Lianeri M; Rubis B; Knuła H; Rybczyńska M; Grodecka-Gazdecka S; Jagodziński PP
DNA Cell Biol; 2010 Aug; 29(8):423-7. PubMed ID: 20406099
[TBL] [Abstract][Full Text] [Related]
8. Association of a LSP1 gene rs3817198T>C polymorphism with breast cancer risk: evidence from 33,920 cases and 35,671 controls.
Chen MB; Li C; Shen WX; Guo YJ; Shen W; Lu PH
Mol Biol Rep; 2011 Oct; 38(7):4687-95. PubMed ID: 21127985
[TBL] [Abstract][Full Text] [Related]
9. Association of the CXCL12 rs1801157 Polymorphism with Breast Cancer Risk: A Meta-Analysis.
Alijanpour A; Golshan A; Vakili-Ojarood M; Shirinzadeh-Dastgiri A; Naseri A; Karimi-Zarchi M; Hajizadeh N; Barahman M; Azizi S; Aghasipour M; Khajehnoori S; Aghili K; Neamatzadeh H
Asian Pac J Cancer Prev; 2024 Mar; 25(3):767-776. PubMed ID: 38546059
[TBL] [Abstract][Full Text] [Related]
10. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
[TBL] [Abstract][Full Text] [Related]
11. CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Dahiya AV; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Sep; 13(17):5056-62. PubMed ID: 17785557
[TBL] [Abstract][Full Text] [Related]
12. TNFalpha -308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls.
Fang F; Yao L; Yu XJ; Yu L; Wu Q; Yu L
Breast Cancer Res Treat; 2010 Jul; 122(1):267-71. PubMed ID: 20035378
[TBL] [Abstract][Full Text] [Related]
13. MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.
Ma Y; Bian J; Cao H
PLoS One; 2013; 8(2):e56918. PubMed ID: 23451111
[TBL] [Abstract][Full Text] [Related]
14. No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis.
Yu KD; Chen AX; Shao ZM
Breast Cancer Res Treat; 2010 Aug; 122(3):853-8. PubMed ID: 20076999
[TBL] [Abstract][Full Text] [Related]
15. Lack of Association between miR-605 rs2043556 Polymorphism and Overall Cancer Risk: A Meta-analysis of Case-control Studies.
Moazeni-Roodi A; Ghavami S; Hashemi M
Microrna; 2019; 8(2):94-100. PubMed ID: 30514199
[TBL] [Abstract][Full Text] [Related]
16. Effect of LEPR Gln223Arg polymorphism on breast cancer risk in different ethnic populations: a meta-analysis.
He BS; Pan YQ; Zhang Y; Xu YQ; Wang SK
Mol Biol Rep; 2012 Mar; 39(3):3117-22. PubMed ID: 21698367
[TBL] [Abstract][Full Text] [Related]
17. CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma.
de Oliveira KB; Oda JM; Voltarelli JC; Nasser TF; Ono MA; Fujita TC; Matsuo T; Watanabe MA
J Clin Lab Anal; 2009; 23(6):387-93. PubMed ID: 19927352
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in KCNJ11 (E23K, rs5219) and SDF-1β (G801A, rs1801157) genes are associated with the risk of type 2 diabetes mellitus.
Rizvi S; Raza ST; Mahdi F; Singh SP; Rajput M; Rahman Q
Br J Biomed Sci; 2018 Jul; 75(3):139-144. PubMed ID: 29893194
[TBL] [Abstract][Full Text] [Related]
19. CXCL12 G801A polymorphism and susceptibility to glioma: a case‑control study.
Chang SF; Li SL; Yang B; Yao KM; Miao RH; Liang GF; Zhang KM
Genet Mol Res; 2015 Dec; 14(4):17399-405. PubMed ID: 26782381
[TBL] [Abstract][Full Text] [Related]
20. COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case-control studies.
Ding H; Fu Y; Chen W; Wang Z
Breast Cancer Res Treat; 2010 Aug; 123(1):265-70. PubMed ID: 20130981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
